脂漏性角化症治療剤の世界市場2019-2023

◆英語タイトル:Global Seborrheic Keratosis Treatment Market 2019-2023
◆商品コード:IRTNTR31094
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年3月27日
◆ページ数:112
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、脂漏性角化症治療剤の世界市場について調査・分析し、市場概要、市場環境、脂漏性角化症治療剤市場規模、種類別(冷凍療法、電気焼灼術、その他治療債)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・脂漏性角化症治療剤の世界市場概要
・脂漏性角化症治療剤の世界市場環境
・脂漏性角化症治療剤の世界市場動向
・脂漏性角化症治療剤の世界市場規模
・脂漏性角化症治療剤の世界市場:業界構造分析
・脂漏性角化症治療剤の世界市場:種類別(冷凍療法、電気焼灼術、その他治療債)
・脂漏性角化症治療剤の世界市場:地域別市場規模・分析
・脂漏性角化症治療剤の北米市場規模・予測
・脂漏性角化症治療剤のヨーロッパ・中東・アフリカ市場規模・予測
・脂漏性角化症治療剤のアジア太平洋市場規模・予測
・脂漏性角化症治療剤の主要国分析
・脂漏性角化症治療剤の世界市場:成長要因、課題
・脂漏性角化症治療剤の世界市場:競争環境
・脂漏性角化症治療剤の世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About this market
The surge in geriatric population will lead the seborrheic keratosis treatment market to witness considerable growth in the forthcoming years. Rapid developments in the healthcare facilities and advanced treatment options have further resulted in increasing the life expectancy of the geriatric population. Rising awareness about the health conditions including seborrheic keratosis will also drive the demand for seborrheic keratosis treatment market during the next few years. Technavio’s analysts have predicted that the seborrheic keratosis market will register a CAGR of over 6% by 2023.
Market Overview
High prevalence of seborrheic keratosis
One of the growth drivers of the global seborrheic keratosis market is the high prevalence of seborrheic keratosis. The increasing awareness about health and the importance of sports is increasing the prevalence of skin conditions, including seborrheic keratosis.
Challenges associated with misdiagnosis
One of the challenges in the growth of the global seborrheic keratosis market is the challenges associated with misdiagnosis. The lack of medical devices for the diagnosis coupled with the camouflaging nature of the symptoms and signs leads to misdiagnosis, which will hamper the market growth.
For the detailed list of factors that will drive and challenge the growth of the seborrheic keratosis market during 019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several market players. Vendors in the market are increasingly focusing on technological advances in cryotherapy equipment that help in the visualization of the cryotherapy experience with thermal imaging. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Cryotherapy – Market size and forecast 2018-2023
• Electrocautery – Market size and forecast 2018-2023
• Other treatments – Market size and forecast 2018-2023
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Aclaris Therapeutics, Inc.
• Brymill Cryogenic Systems
• CryoConcepts LP
• OLYMPUS CORPORATION
• Special Medical Technology Co., Ltd.
PART 13: APPENDIX
• Research methodology
• List of abbreviations


Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: – Market share 2018-2023 (%)
Exhibit 18: Comparison by type
Exhibit 19: Cryotherapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Cryotherapy – Year-over-year growth 2019-2023 (%)
Exhibit 21: Electrocautery – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Electrocautery – Year-over-year growth 2019-2023 (%)
Exhibit 23: Other treatments – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Other treatments – Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by type
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America – Year-over-year growth 2019-2023 (%)
Exhibit 31: Top 3 countries in North America
Exhibit 32: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 34: Top 3 countries in Europe
Exhibit 35: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 37: Top 3 countries in Asia
Exhibit 38: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 39: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 40: Top 3 countries in ROW
Exhibit 41: Market opportunity
Exhibit 42: Growth in geriatric population 2013-2017 (%)
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Aclaris Therapeutics, Inc. – Vendor overview
Exhibit 50: Aclaris Therapeutics, Inc. – Business segments
Exhibit 51: Aclaris Therapeutics, Inc. – Organizational developments
Exhibit 52: Aclaris Therapeutics, Inc. – Segment focus
Exhibit 53: Aclaris Therapeutics, Inc. – Key offerings
Exhibit 54: Aclaris Therapeutics, Inc. – Key customers
Exhibit 55: Brymill Cryogenic Systems – Vendor overview
Exhibit 56: Brymill Cryogenic Systems – Key offerings
Exhibit 57: Brymill Cryogenic Systems – Key customers
Exhibit 58: CryoConcepts LP – Vendor overview
Exhibit 59: CryoConcepts LP – Key offerings
Exhibit 60: CryoConcepts LP – Key customers
Exhibit 61: OLYMPUS CORPORATION – Vendor overview
Exhibit 62: OLYMPUS CORPORATION – Business segments
Exhibit 63: OLYMPUS CORPORATION – Organizational developments
Exhibit 64: OLYMPUS CORPORATION – Geographic focus
Exhibit 65: OLYMPUS CORPORATION – Segment focus
Exhibit 66: OLYMPUS CORPORATION – Key offerings
Exhibit 67: OLYMPUS CORPORATION – Key customers
Exhibit 68: Special Medical Technology Co., Ltd. – Vendor overview
Exhibit 69: Special Medical Technology Co., Ltd. – Key offerings
Exhibit 70: Special Medical Technology Co., Ltd. – Key customers
Exhibit 71: Validation techniques employed for market sizing



【掲載企業】

Aclaris Therapeutics, Inc., Brymill Cryogenic Systems, CryoConcepts LP, OLYMPUS CORPORATION, Special Medical Technology Co., Ltd.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[脂漏性角化症治療剤の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆